Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02783300 |
Title | Dose Escalation Study of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma (NHL) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications |
triple-receptor negative breast cancer ureter transitional cell carcinoma renal pelvis transitional cell carcinoma |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | CAN |